TY - JOUR
T1 - Latest Comprehensive Medical Resource Consumption in Robot-Assisted versus Laparoscopic and Traditional Open Radical Prostatectomy
T2 - A Nationwide Population-Based Cohort Study
AU - Wu, Szu-Yuan
AU - Chang, Shyh-Chyi
AU - Chen, Chang-I
AU - Huang, Chung-Chien
N1 - Funding Information:
Author Contributions: Conception and Design: C.-C.H., S.-C.C., S.-Y.W., C.-I.C. Financial Support: Lo-Hsu Medical Foundation, LotungPoh-Ai Hospital, supports S.-Y.W.’s work (Funding Number: 10908, 10909, 11001, 11002, 11003, 11006, and 11013). Collection and Assembly of Data: C.-C.H., S.-Y.W., C.-I.C. Data Analysis and Interpretation: C.-C.H., S.-Y.W., C.-I.C. Administrative Support: S.-Y.W. Manuscript Writing: C.-C.H., S.-C.C., S.-Y.W., C.-I.C. Final Approval of Manuscript: All authors. All authors have read and agreed to the published version of the manuscript.
Funding Information:
Lo-Hsu Medical Foundation, LotungPoh-Ai Hospital, supports S.-Y.W.?s work (Funding Number: 10908, 10909, 11001, 11002, 11003, 11006, and 11013). MOST 108-2745-8-038-007 supports C.-I.C.?s work.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/3/29
Y1 - 2021/3/29
N2 - BACKGROUND: Few studies have evaluated long-term medical monetary cost in patients with prostate cancer (PC) receiving open radical prostatectomy (ORP), laparoscopic radical prostatectomy (LRP), or robot-assisted radical prostatectomy (RARP). To the best of our knowledge, this is the largest and longest follow-up study to examine medical monetary cost in patients with PC undergoing ORP, LRP, or RARP. After adjustment for confounders, the medical monetary cost in the RARP group was the least compared with that in the ORP and LRP groups.PURPOSE: To estimate long-term medical resource consumption among patients with prostate cancer (PC) receiving open radical prostatectomy (ORP), laparoscopic radical prostatectomy (LRP), or robot-assisted radical prostatectomy (RARP).PATIENTS AND METHODS: Participants were men enrolled in the Taiwan Cancer Registry with localized PC diagnosis who received radical prostatectomy. After adjustment for confounders, a generalized linear mixed model was used to determine significant differences in the number of urology outpatient clinic visits required, proportion of patients being hospitalized for urinary diseases or surgical complications, and medical reimbursement for urinary diseases or surgical complications following ORP, LRP, or RARP in the first, second, and third years. Results: No differences were observed in the median number of urology outpatient clinic visits between the three types of surgical modalities up to the second year after ORP, LRP, and RARP (median: 15, 10, and seven visits, respectively; p < 0.001), but significant differences were observed in the third year. Similarly, with RARP (10.9% versus 18.7% in ORP and 9.8% in LRP; p = 0.0014), the rate of hospitalization for urinary diseases or surgical complications decreased in the third year. Medical reimbursement for urinary diseases or surgical complications reduced after RARP compared with that for ORP and LRP, with approximately 22% reduction in the first year (p = 0.0052) and 20-40% reduction in the third year (p value = 0.0024).CONCLUSIONS: Medical resource consumption in the RARP group was less compared with those in the ORP and LRP groups.
AB - BACKGROUND: Few studies have evaluated long-term medical monetary cost in patients with prostate cancer (PC) receiving open radical prostatectomy (ORP), laparoscopic radical prostatectomy (LRP), or robot-assisted radical prostatectomy (RARP). To the best of our knowledge, this is the largest and longest follow-up study to examine medical monetary cost in patients with PC undergoing ORP, LRP, or RARP. After adjustment for confounders, the medical monetary cost in the RARP group was the least compared with that in the ORP and LRP groups.PURPOSE: To estimate long-term medical resource consumption among patients with prostate cancer (PC) receiving open radical prostatectomy (ORP), laparoscopic radical prostatectomy (LRP), or robot-assisted radical prostatectomy (RARP).PATIENTS AND METHODS: Participants were men enrolled in the Taiwan Cancer Registry with localized PC diagnosis who received radical prostatectomy. After adjustment for confounders, a generalized linear mixed model was used to determine significant differences in the number of urology outpatient clinic visits required, proportion of patients being hospitalized for urinary diseases or surgical complications, and medical reimbursement for urinary diseases or surgical complications following ORP, LRP, or RARP in the first, second, and third years. Results: No differences were observed in the median number of urology outpatient clinic visits between the three types of surgical modalities up to the second year after ORP, LRP, and RARP (median: 15, 10, and seven visits, respectively; p < 0.001), but significant differences were observed in the third year. Similarly, with RARP (10.9% versus 18.7% in ORP and 9.8% in LRP; p = 0.0014), the rate of hospitalization for urinary diseases or surgical complications decreased in the third year. Medical reimbursement for urinary diseases or surgical complications reduced after RARP compared with that for ORP and LRP, with approximately 22% reduction in the first year (p = 0.0052) and 20-40% reduction in the third year (p value = 0.0024).CONCLUSIONS: Medical resource consumption in the RARP group was less compared with those in the ORP and LRP groups.
KW - Hospitalization
KW - Laparoscopic radical prostatectomy
KW - Medical reimbursement
KW - Open radical prostatectomy
KW - Robotic radical prostatectomy
UR - http://www.scopus.com/inward/record.url?scp=85103112984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103112984&partnerID=8YFLogxK
U2 - 10.3390/cancers13071564
DO - 10.3390/cancers13071564
M3 - Article
C2 - 33805354
SN - 2072-6694
VL - 13
JO - Cancers
JF - Cancers
IS - 7
M1 - 1564
ER -
